Vaccination against Covid-19 will begin this week in the EU’s countries


The European Union has authorized the Pfizer/BioNTech Covid-19 vaccine. The first phase of the bloc’s mass program will begin later this week. It was concluded that the vaccine is safe and effective against Covid-19. Ursula von der Leyen, President of the European Commission, called it “an important chapter” in the EU’s fight against Covid-19. “This is a very good way to end this difficult year, and to finally start turning the page on Covid-19,” von der Leyen said.


The commission has secured over 2 billion doses of potential vaccines in a move to ensure equitable access across the bloc. That agreement includes the procurement of 300 million doses of the Pfizer/BioNTech vaccine, which is enough to vaccinate 150 million of the EU’s 448 million citizens. The other available vaccine at the time, from Moderna, will also be evaluated soon. Experts said that people should continue to keep wearing masks, socially distance and wash their hands. The European Commission has emphasized that all EU countries will begin vaccinations on the same day, December 27.